A small series of norbornane bisether diguanidines have been synthesized and evaluated as antibacterial agents. The key transformation-bisalkylation of norbornane diol 6-was not successful using Williamson methodology but has been accomplished using Ag 2 O mediated alkylation. Further functionalization to incorporate two guanidinium groups gave rise to a series of structurally rigid cationic amphiphiles; several of which (16d, 16g and 16h) exhibited antibiotic activity. For example, compound 16d was active against a broad range of bacteria including Pseudomonas aeruginosa (MIC = 8 µg/mL), Escherichia coli (MIC = 8 µg/mL) and methicillin-resistant Staphylococcus aureus (MIC = 8 µg/mL).
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exacerbate the problem. [1] [2] [3] [4] [5] Many antibacterial agents that target the lipopolysaccharide (LPS) layer of Gram-negative bacteria either possess or adopt an amphiphilic structure. [6] [7] [8] [9] [10] It has also been shown that appropriate functionalization of a rigidified core (such as a calixarene) enables facially amphiphilic compounds to be constructed. [7] [8] [9] [10] [11] The bicyclo[2.2.1]heptane (norbornane) scaffold represents one of the most accessible, preorganized frameworks available and has a history of use in many fields of chemistry. Biologically active examples include: naxifylline 1 (an A 1 -adenosine receptor antagonist), 12 N 6 -(5,6-epoxynorbornyl)adenonsines (A 1 -adenosine receptor agonists) [13] [14] [15] and diguanidine 3, (active against Gram-negative bacteria). 16 In supramolecular chemistry norbornanes have found use in organogel formation, 17 whilst fused polynorbornanes have been successfully employed as scaffolds for both anion recognition, [18] [19] [20] [21] and as ligands for the construction of metalorganic cages. 22 In the field of asymmetric synthesis, chiral auxiliaries (such as 2) based on the norbornane framework have also been successfully employed. 23, 24 It is known that ethers typically demonstrate better in vivo stability than acetals, 25 therefore, analogs of antibacterial 3 16 (Figure 1 ) that followed the general structure 4 (Scheme 1) were considered attractive targets. In order to construct this class of compounds it was envisaged that bisether diacids (5) would be useful building blocks and these could in turn be synthesized from norbornane diol 6 (Scheme 1). of 6). Pleasingly, when the reaction was performed on a larger scale (900 mg of 6), the yield increased to 37%. A Finkelstein approach 46 using NaI did not increase the yield of bisether diacid 12b. The low yields can be rationalized somewhat by the steric bulk introduced as a result of the first benzylationthe reaction with the second equivalent benzyl halide is considerably inhibited. Indeed, an appreciable amounts of the monoalkylated regioisomer (37%) were isolated along with the desired bisether product 12b.
Similarly, using 2-methylbenzyl bromide, 12c was accessed in a 19% yield ( Table 1 , entry 3), and a reasonable quantity of a monoalkylated intermediate was isolated (39 %) . However, despite the modest yields, this protocol provided access to the desired norbornane bisethers-a previously inaccessible family of compounds.
When a range of fluorinated benzyl bromides were used good yields of the desired bisether products were obtained. Following the aforementioned two-step process, 12d (51%) and 12e (55%) were accessed in good yields using 4-(trifluoromethyl)benzyl bromide and 3-fluorobenzyl bromide respectively ( Table 1 , entries 4 and 5). Furthermore, when 4-fluorobenzyl bromide was employed to alkylate diol 6, and following hydrolysis of the ester groups using NaOH/THF ( Table 1, entry 6) diacid 12f was obtained in moderate yield (25%) over the two steps. Using 3-bromobenzyl bromide and 4-bromobenzyl bromide the synthesis of bisether diacids 12g and 12h (24 and 28% over two steps respectively, Table 1 , entries 7 and 8) were carried out in the same fashion. Crystals suitable for X-ray diffraction were obtained for bisether diacid 12h after recrystallization from EtOH/pet. spirits. The resulting structure contained a unit cell comprised of two conformational isomers (as shown in Figure 2 ). The O···O distance (ca. 2.6 Å), clearly illustrates the proximity of the two benzyl groups and their non-symmetric orientation (presumably due to steric constraints). When allyl bromide was used stirring for 4 days was required to consume all the starting material; subsequent ester hydrolysis gave diacid 12i in a 25% yield over the two steps ( In six of the alkylation reactions (12b, 12d-12h) transesterification occurred to a small extent (6-12%, as determined using 1 H NMR spectroscopy). This mixed-ester side-product (example 13 from synthesis of 9b, Figure 3 ) was difficult to separate from the desired dimethyl ester product using column chromatography. The presumption that the more sterically accessible exo methyl ester was replaced is based on a previous report by Niwayama and co-workers that illustrated how the exo face is less hindered than the endo face of related norbornane diesters. 40 Despite the presence of small amounts of mixed-ester by-products, in each case hydrolysis proceeded smoothly and pure diacids were isolated in every instance. With bisethers diacids (12a-12i) in hand, functionalization to the required amphiphiles was pursued.
Attachment of 2-[2,3-bis(tert-butoxycarbonyl)guanidino]ethylamine (14) 47, 48 to the norbornane scaffold was carried out using EDCI and HOBt in either DMF or CHCl 3 using microwave irradiation at 50 °C for 30 minutes to give compounds 15a-15i in moderate to good yields (26-72%, Table 2 ).
Subsequent deprotection was accomplished using HCl (generated in situ from AcCl in MeOH) to give the desired guanidines as the guanidinium chloride salts (16a-16i, Table 2 ).
A balance of both hydrophobicity and hydrophilicity is essential for the antibacterial activity of structural amphiphiles. 49 In light of this, the calculated LogP (cLogP) values (the log of the octanol/water partition coefficient) were determined for bisether diguanidines (16a-16i) using www.molinspiration.com software ( Table 2 ) and these will be discussed in relation to activity in the following section. 
Biological evaluation
The antibacterial activity of these compounds was evaluated against a range of Gram-negative and Gram-positive bacteria, including members of the ESKAPE pathogens; 1 first using the disk diffusion assay to identify active compounds then micro-broth dilution assays to determine minimum inhibitory concentrations (MICs).
Bis-methyl ether 16a and allyl ether 16i, did not show any inhibition in disk diffusion studies at 50 µg/disk ( 
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ZOI's (11-15 mm) were also observed against Gram-positive methicillin-resistant Staphylococcus aureus (MRSA). When larger substituents occupied the 4-position of the phenyl ring, inhibition of vancomycin-resistant Enterococcus faecium (VRE) was also seen in addition to the aforementioned strains. The 4-(trifluoromethyl)benzyl (16d) and 4-bromobenzyl (16h) analogs showed ZOI of 18 and 16 mm respectively for VRE ( Table 3 ). The 3-bromobenzyl derivative (16g) was active against all pathogens assessed in this study, and was the sole compound to exhibit activity against Acinetobacter baumannii (ZOI = 15 mm). Comparison of ZOI between 16g and 16h indicates that activity against A. baumannii, K. pneumoniae and E. faecium can be influenced by subtle changes to substituent locations and may have implications in the design of subsequent compounds. Given the promising results in the disk diffusion screen the substituted benzyl ethers were subjected to a micro-broth dilution assay to quantify MICs ( (Table 4 ). A correlation between antibacterial activity and cLogP was apparent with compounds with higher cLogP values ( Table 2) showing stronger antibacterial activity. Table 5 ). The 4-(trifluoromethyl)benzyl bisether (16d) was again the most active compound;
exhibiting antibacterial activity (MIC = 8-16 µg/mL) against all eight bacterial strains tested.
Furthermore, activity was observed by 3-bromobenzyl bisether (16g) against all Gram-positive bacterial strains tested which was highlighted by an MIC of 8 µg/mL against S. pneumoniae (Table 4 ).
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The cell viability (% survival) against human embryonic kidney cells (HEK293) and hepatocellular carcinoma (HepG2) was determined after exposure to compounds 16d or 16g at 100 µM for 24 hours (Table 6 ). The 4-(trifluoromethyl)benzyl bisether (16d) exhibited moderate cytotoxicity with 43 and 56% cell survival observed against HEK293 and HepG2 respectively ( Table 5 ). In the case of bis-3bromobenzyl ether (16g) the cell viability was determined to be 90% and 96% against HEK293 and HepG2 respectively (IC 50 < 100 µM). The cytotoxicity profile for these compounds is acceptable when compared to previously reported antibacterial agents. 50 
Conclusions
The previously inaccessible norbornane bisether diacids 12a-i, were successfully prepared using pneumonia, E. faecalis and several strains of S. aureus. The results presented here reinforce the notion that the activity of cationic antimicrobial peptides can be mimicked by relatively small, structurally rigid amphiphiles. Indeed, when compared to other synthetic scaffolds (such as calixarenes) which are used to generate antibacterial amphiphiles, 9 the low molecular weight of these compounds and their reasonable antibacterial activity make them an attractive class of compounds worthy of further investigation.
Experimental Section
The following compounds were prepared using literature methods and full reaction details can be found in the supplementary information; All chemicals and solvents were used as received without further purification unless otherwise stated.
Column chromatography was performed on silica gel (230-400 mesh). 
5,6-Bis(benzyloxy) bicyclo[2.2.1]heptane-3-endo-2-exo-dicarboxylic acid (12b). The title
compound 12b was prepared from diester 9b (717 mg, 1.69 mmol) according to general procedure B and isolated as a white powder (525 mg, 78%). 1 [2ʹ-(2ʺ,3ʺ-di-tert-butoxycarbonylguanidino) 13 13 
5,6-Bis(3-bromobenzyloxy) bicyclo[2.2.1]heptane-3-endo-2-exo-dicarboxylic acid (12g
5,6-Bis(4-bromobenzyloxy) bicyclo[2.2.1]heptane-3-endo-2-exo-dicarboxylic acid (12h
3-endo-2-exo-Di
3-endo-2-exo-Di[2ʹ-(2ʺ,3ʺ-di-tert-butoxycarbonylguanidino)ethylcarbamoyl]-5,6-bis(4bromobenzyloxy)bicyclo[2.2.1]heptane (15h).
Compound 15h was prepared from diacid 12h (171 mg, 0.31 mmol) and amine 14 (281 mg, 0.93 mmol) according to general procedure C and after purification by column chromatography (50-70% EtOAc in pet. spirits) was isolated as a clear oil (91 mg, 26%); R f = 0.48 (70% EtOAc in pet. spirits). 1 
3-endo-2-exo-Di[2ʹ-(2ʺ,3ʺ-di-tert-butoxycarbonylguanidino)ethylcarbamoyl]-5,6bis(allyloxy)bicyclo[2.2.1]heptane (15i).
Compound 15i was prepared from diacid 12i (70 mg, 0.24 mmol) and amine 14 (214 mg, 0.71 mmol) according to general procedure C and after purification by column chromatography (50-70% EtOAc in pet. spirits) was isolated as a clear oil (128 mg, 63%); R f = 0.34 (70% EtOAc in pet. spirits). 1 13 
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vacuo to afford the crude material that was purified by column chromatography (as specified below)
to give the title compound. General procedure E for boc-removal of Boc-protected guanidines 15a-i. To the stirring solution of Boc-protected guanidine (0.05 mmol) and MeOH (520 µL), was added dropwise AcCl (20 equiv) and the reaction was stirred for 24 h at ambient temperature. The reaction mixture was concentrated under vacuum and the product was co-evaporated with MeOH (2 × 0.5 mL) to give the desired guandinium HCl salt. 
3-endo-2-exo-Di
5,6-Bis(methoxy)bicyclo[2.2.1]heptane-3-endo-2-exo-dicarboxamidoethylguanidine
